CD2-ASSOCIATED PROTEIN (CD2AP) AND ITS INTERACTIVE PROTEINS
A method for down-regulating CD2AP expression in a subject comprises administering a CD2AP down-regulation composition to the subject, wherein the CD2AP down regulation composition is workable by way of siRNA/shRNA, Crispr/cas9, crispr/cpf1, Talen or ZFNs; thereby the CD2AP expression in liver tissu...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French |
Published |
20.12.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A method for down-regulating CD2AP expression in a subject comprises administering a CD2AP down-regulation composition to the subject, wherein the CD2AP down regulation composition is workable by way of siRNA/shRNA, Crispr/cas9, crispr/cpf1, Talen or ZFNs; thereby the CD2AP expression in liver tissues of the subject is down-regulated.
La présente invention concerne un procédé de régulation à la baisse de l'expression de CD2AP chez un sujet qui consiste à administrer au sujet une composition de régulation à la baisse de CD2AP, la composition de régulation à la baisse de CD2AP étant utilisable au moyen d'ARNsi/shARN, de CRISPR/cas9, de CRISPR/cpf1, de Talen ou de NDZ ; ainsi, l'expression de CD2AP dans les tissus du foie du sujet est régulée à la baisse. |
---|---|
Bibliography: | Application Number: WO2017CN88258 |